{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:09:36Z","timestamp":1746331776022,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00380-020-01731-9","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T09:03:41Z","timestamp":1605949421000},"page":"605-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of malondialdehyde-modified low-density lipoprotein on clinical outcomes after fractional flow reserve-guided deferral of revascularization"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-9568","authenticated-orcid":false,"given":"Masashi","family":"Yokoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ohte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,21]]},"reference":[{"issue":"26","key":"1731_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1056\/NEJM199606273342604","volume":"334","author":"NH Pijls","year":"1996","unstructured":"Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Koolen BJ, Koolen JJ (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334(26):1703\u20131708","journal-title":"N Engl J Med"},{"issue":"21","key":"1731_CR2","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.jacc.2016.08.055","volume":"68","author":"E Barbato","year":"2016","unstructured":"Barbato E, Toth GG, Johnson NP, Pijls NH, Fearon WF, Tonino PA, Curzen N, Piroth Z, Rioufol G, J\u00fcni P, De Bruyne B (2016) A prospective natural history study of coronary atherosclerosis using fractional flow reserve. J Am Coll Cardiol 68(21):2247\u20132255","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1731_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1056\/NEJMoa1803538","volume":"379","author":"P Xaplanteris","year":"2018","unstructured":"Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, Engstr\u00f8m T, K\u00e4\u00e4b S, Dambrink JH, Rioufol G, Toth GG, Piroth Z, Witt N, Fr\u00f6bert O, Kala P, Linke A, Jagic N, Mates M, Mavromatis K, Samady H, Irimpen A, Oldroyd K, Campo G, Rothenb\u00fchler M, J\u00fcni P, De Bruyne B, FAME 2 Investigators (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379(3):250\u2013259","journal-title":"N Engl J Med"},{"issue":"45","key":"1731_CR4","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","volume":"36","author":"FM Zimmermann","year":"2015","unstructured":"Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, Erbel R, Legrand V, Gwon HC, Remkes WS, Stella PR, van Schaardenburgh P, Bech GJ, De Bruyne B, Pijls NH (2015) Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 36(45):3182\u20133188","journal-title":"Eur Heart J"},{"key":"1731_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-016-0417-2","volume":"15","author":"MW Kennedy","year":"2016","unstructured":"Kennedy MW, Kaplan E, Hermanides RS, Fabris E, Hemradj V, Koopmans PC, Dambrink JH, Marcel Gosselink AT, Van\u2019t Hof AW, Ottervanger JP, Roolvink V, Remkes WS, van der Sluis A, Suryapranata H, Kedhi E (2016) Clinical outcomes of deferred revascularization using fractional flow reserve in patients with and without diabetes mellitus. Cardiovasc Diabetol 15:100","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"1731_CR6","doi-asserted-by":"publisher","first-page":"e002172","DOI":"10.1161\/JAHA.115.002172","volume":"4","author":"S Masrani Mehta","year":"2015","unstructured":"Masrani Mehta S, Depta JP, Novak E, Patel JS, Patel Y, Raymer D, Facey G, Zajarias A, Lasala JM, Singh J, Bach RG, Kurz HI (2015) Association of lower fractional flow reserve values with higher risk of adverse cardiac events for lesions deferred revascularization among patients with acute coronary syndrome. J Am Heart Assoc 4(8):e002172","journal-title":"J Am Heart Assoc"},{"key":"1731_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijcard.2018.06.013","volume":"270","author":"U Barbero","year":"2018","unstructured":"Barbero U, D\u2019Ascenzo F, Campo G, Kleczy\u0144ski P, Dziewierz A, Menozzi M, Jim\u00e9nez D\u00edaz VA, Cerrato E, Raposeiras-Roub\u00edn S, Ielasi A, Rognoni A, Fineschi M, Kanji R, Jaguszewski MJ, Picchi A, And\u00f2 G, Soraci E, Mancone M, Sardella G, Calcagno S, Gallo F, Huczek Z, Krakowian M, Verardi R, Montefusco A, Omed\u00e8 P, Lococo M, Moretti C, D\u2019Amico M, Rigattieri S, Gaita F, Rinaldi M, Escaned J (2018) Safety of FFR-guided revascularization deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): a prospective multicentre study. Int J Cardiol 270:107\u2013112","journal-title":"Int J Cardiol"},{"issue":"9","key":"1731_CR8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1253\/circj.CJ-16-1213","volume":"81","author":"N Tanaka","year":"2017","unstructured":"Tanaka N, Nakamura M, Akasaka T, Kadota K, Uemura S, Amano T, Shiode N, Morino Y, Fujii K, Hikichi Y, Registry CVIT-DEFER, Investigators. (2017) One-year outcome of fractional flow reserve-based coronary intervention in japanese daily practice-CVIT-DEFER registry. Circ J 81(9):1301\u20131306","journal-title":"Circ J"},{"issue":"9","key":"1731_CR9","first-page":"410","volume":"27","author":"JH Doh","year":"2015","unstructured":"Doh JH, Nam CW, Koo BK, Park SH, Lee JH, Han JK, Yang HM, Lim HS, Yoon MH, Cho YK, Hur SH, Lee SY, Kim HS, Tahk SJ (2015) Long-term patient-related and lesion-related outcomes after real-world fractional flow reserve use. J Invasive Cardiol 27(9):410\u2013415","journal-title":"J Invasive Cardiol"},{"issue":"24","key":"1731_CR10","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41(24):2313\u20132330","journal-title":"Eur Heart J"},{"key":"1731_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1136\/hrt.2003.018226","volume":"90","author":"T Amaki","year":"2004","unstructured":"Amaki T, Suzuki T, Nakamura F, Hayashi D, Imai Y, Morita H, Fukino K, Nojiri T, Kitano S, Hibi N, Yamazaki T, Nagai R (2004) Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease. Heart 90:1211\u20131213","journal-title":"Heart"},{"key":"1731_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ehjci\/jes094","volume":"14","author":"Y Matsuo","year":"2013","unstructured":"Matsuo Y, Kubo T, Okumoto Y, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Hirata K, Imanishi T, Akagi H, Akasaka T (2013) Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease. Eur Heart J Cardiovasc Imaging 14:43\u201350","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"1731_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00380-017-1074-4","volume":"33","author":"T Ito","year":"2018","unstructured":"Ito T, Ichihashi T, Fujita H, Sugiura T, Ohte N (2018) Impact of malondialdehyde-modified low-density lipoprotein on coronary plaque vulnerability in patients not receiving lipid-lowering therapy: a whole coronary analysis with multislice-computed tomography. Heart Vessels 33(4):351\u2013357","journal-title":"Heart Vessels"},{"issue":"10","key":"1731_CR14","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1253\/circj.CJ-20-0060","volume":"84","author":"M Yokoi","year":"2020","unstructured":"Yokoi M, Ito T, Fujita H, Sugiura T, Seo Y, Ohte N (2020) Increased serum malondialdehyde-modified low-density lipoprotein and coronary angiographic progression after drug-eluting stent implantation in patients with stable angina. Circ J 84(10):1837\u20131845","journal-title":"Circ J"},{"key":"1731_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.atherosclerosis.2015.01.026","volume":"239","author":"T Ito","year":"2015","unstructured":"Ito T, Fujita H, Tani T, Ohte N (2015) Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent. Atherosclerosis 239:311\u2013317","journal-title":"Atherosclerosis"},{"key":"1731_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0005-2760(94)90100-7","volume":"1215","author":"K Kotani","year":"1994","unstructured":"Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M (1994) Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta (BBA)\/Lipids Lipid Metab 1215:121\u2013125","journal-title":"Biochim Biophys Acta (BBA)\/Lipids Lipid Metab"},{"key":"1731_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/clinchem\/44.3.522","volume":"44","author":"H Sugiuchi","year":"1998","unstructured":"Sugiuchi H, Irie T, Uji Y, Ueno T, Chaen T, Uekama K, Okabe H (1998) Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and \u03b1-cyclodextrin sulfate. Clin Chem 44:522\u2013531","journal-title":"Clin Chem"},{"key":"1731_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5551\/jat.19737","volume":"21","author":"T Teramoto","year":"2014","unstructured":"Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K, Japan Atherosclerosis Society Committee for Epidemiology and Clinical Management of Atherosclerosis (2014) Diagnosis of atherosclerosis: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb 21:296\u2013298","journal-title":"J Atheroscler Thromb"},{"issue":"9","key":"1731_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.5551\/jat.GL2017","volume":"25","author":"M Kinoshita","year":"2018","unstructured":"Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Committee for Epidemiology and Clinical Management of Atherosclerosis (2018) Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb 25(9):846\u2013984","journal-title":"J Atheroscler Thromb"},{"issue":"18","key":"1731_CR20","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Executive Group on behalf of the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction (2018) Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 72(18):2231\u20132264","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1731_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jjcc.2018.05.018","volume":"73","author":"N Tanaka","year":"2019","unstructured":"Tanaka N, Kohsaka S, Murata T, Akasaka T, Kadota K, Uemura S, Amano T, Shiode N, Morino Y, Fujii K, Hikichi Y, Nakamura M (2019) Treatment strategy modification and its implication on the medical cost of fractional flow reserve-guided percutaneous coronary intervention in Japan. J Cardiol 73(1):38\u201344","journal-title":"J Cardiol"},{"issue":"3","key":"1731_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00380-018-1260-z","volume":"34","author":"R Hamaya","year":"2019","unstructured":"Hamaya R, Yonetsu T, Kanaji Y, Usui E, Hoshino M, Hada M, Kanno Y, Murai T, Lee T, Kakuta T (2019) Interrelationship in the prognostic efficacy of reginal coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-pro BNP in patients with stable coronary artery disease. Heart Vessels 34(3):410\u2013418","journal-title":"Heart Vessels"},{"issue":"1","key":"1731_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","volume":"25","author":"NR Madamanchi","year":"2005","unstructured":"Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25(1):29\u201338","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"1731_CR24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/ATVBAHA.110.221127","volume":"31","author":"K Ley","year":"2011","unstructured":"Ley K, Miller YI, Hedrick CC (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 31(7):1506\u20131516","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-020-01731-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T03:28:10Z","timestamp":1617938890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-020-01731-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,21]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01731-9","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"type":"print","value":"0910-8327"},{"type":"electronic","value":"1615-2573"}],"subject":[],"published":{"date-parts":[[2020,11,21]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}